Med-X (MXRX) Ending Cash Position: $-0.26 Mil (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Med-X Ending Cash Position?

Med-X MXRX Ending Cash Position is $-0.26 Mil as of Dec. 2022.

Med-X's Ending Cash Position for the quarter that ended in Dec. 2022 was $-0.26 Mil.

Med-X's quarterly Ending Cash Position increased from Dec. 2021 ($0.18 Mil) to Jun. 2022 ($0.47 Mil) but then declined from Jun. 2022 ($0.47 Mil) to Dec. 2022 ($-0.26 Mil).

Med-X's annual Ending Cash Position increased from Dec. 2020 ($0.75 Mil) to Dec. 2021 ($1.37 Mil) but then declined from Dec. 2021 ($1.37 Mil) to Dec. 2022 ($0.21 Mil).

Med-X Ending Cash Position Related Terms

Med-X Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Med-X's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Med-X Ending Cash Position Chart

Med-X Annual Data
Trend Dec20 Dec21 Dec22
Ending Cash Position
0.75 1.37 0.21

Med-X Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22
Ending Cash Position 0.00 1.19 0.18 0.47 -0.26

Med-X Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Med-X's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.367+-1.158
=0.21

Med-X's Ending Cash Position for the quarter that ended in Dec. 2022 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=2.2204460492503E-16+-0.264
=-0.26

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $-0.26 Mil mean?
Med-X (MXRX) has a Ending Cash Position of $-0.26 Mil as of Dec. 2022. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Med-X and its competitors.
Is Med-X's Ending Cash Position too high?
Med-X's current Ending Cash Position is $-0.26 Mil.
How does Med-X's Ending Cash Position compare to ?
Med-X's Ending Cash Position of $-0.26 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Consumer Packaged Goods company?
A good Ending Cash Position depends on the Consumer Packaged Goods industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Med-X and its competitors. Med-X's current Ending Cash Position is $-0.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med-X stock overvalued right now?
Med-X (MXRX) has a current Ending Cash Position of $-0.26 Mil. The current Ending Cash Position is $-0.26 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Med-X (MXRX), the current Ending Cash Position is $-0.26 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Med-X Business Description

Comparable Companies
Address 8236 Remmet Avenue, Canoga Park, CA, USA, 91304
Med-X Inc is engaged in the business of product development, distribution, and marketing of products, which currently consist of Nature-Cide, Thermal-Aid, and Malibu Brands. Nature-Cide products include natural essential oil blends of indoor and outdoor pesticide/insecticide/repellent developed for multiple industries, including professional pest control, turf care, janitorial, hospitality, transportation, and agriculture. Thermal-Aid, Thermal-Aid Zoo, and the Thermal-Aid Headache Relief System are natural heating/cooling pain and physical therapy products for painful ailments affecting adults, children, and animals. Nature-Cide. Malibu Brands has only one product available, an all-natural essential oil pain management cream.